Anatomy of an aftermath: Movie being planned about Melinda Elkins Dawson

It probably is assumed by most people that Melinda Elkins Dawsons story had a definitive end.

In June of 1998, Dawsons mother, Judith Johnson of Barberton, was raped and murdered. A

6-year-old niece also was attacked and raped. Dawsons then-husband, Clarence Elkins, was charged with the crimes, based on the childs account to police.

After Clarence Elkins went to prison, Dawson took it upon herself to prove his innocence, an effort that took seven years.

Clarence Elkins eventually was able to surreptitiously acquire DNA evidence via a cigarette butt from Earl G. Mann, Johnsons former neighbor, who also happened to be imprisoned with Elkins. It matched DNA found at the crime scene. Mann eventually pleaded guilty.

After Elkins was exonerated and released from prison in 2006, he reached a $1.075 million settlement with the state. In 2010, the Elkins family settled a $5.25 million federal lawsuit against the Barberton Police Department. A suit against the Summit County Prosecutors Office was dismissed.

Dawsons life story recently was optioned by movie producer/screenwriter David Massar, who said a script is in development. Massar said he would like to shoot parts of the film in Barberton, Akron and the Magnolia area. The Elkinses were living outside of Magnolia in Carroll County when Clarence Elkins was arrested. The couple divorced in 2007.

TAX FIGHT

But these days, Dawson is fighting a different battle, this one with the Internal Revenue Service, which has informed her that she owes taxes on her share of the compensation money received from the federal suit.

We should not have to fight for something that was rightfully awarded to my sons, myself, and Clarence, she said. There needs to be an amendment to the federal tax law that will cover this subject, not only for my family but for the countless other families that will face this issue one day.

Excerpt from:
Anatomy of an aftermath: Movie being planned about Melinda Elkins Dawson

Anatomy of a Successful PPC Ad

So much technical work goes into your online marketing that you may get lost in the minutiae. Sometimes its easy to forget that creative advertising still matters.

A great example: ad copywriting, which plays a crucial factor in your companys success. Nowhere is this more evident than in PPC advertising, where you have little time to capture the attention of a potential customer.

Stop dwelling on audience targeting and all of the technical settings you can use. Its far more important to write ad copy that resonates with your customers.

Understanding the elements of a successful PPC ad include will:

There are five important PPC ad copy elements that will affect your prospects decision to take action and click through on your ad, and then once on your page to convert to a customer.

Your potential visitor is looking for a solution to their pain points. In fact, customers care about solving their problem, not necessarily buying your product. You must convince them that you will solve those pain points (support, new products, and services).

Saving money is a huge perceived value. Everyone wants to save money by finding a cheap way to solve their problem (or even better, solve the problem free of cost!). Your ad copy should emphasize what problem youll be solving for the user.

While your customers want to solve their problem, they also want to guard against the risk of wasting time and money. This is why risk reversal is such an important element of your ad copy.

To help users guard against risk, you must convince them of the value of clicking on your ad and not wasting time by getting suckered in to something that doesnt work for them.

At every step of the way, you want to reduce the friction of taking the next step. Convince users of the value of clicking on your ad, and you will get more relevant visitors.

Continued here:
Anatomy of a Successful PPC Ad

Research and Markets: Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/j6vkjm/finland_neurology) has announced the addition of Global Markets Direct's new report "Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

This new report by Global Markets Direct provides key market data on the Finland Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Finland Neurology Devicesmarket.

- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Natus Medical Incorporated, Cadwell Laboratories, Inc., Stryker Corporation, B. Braun Melsungen AG and others.

Go here to see the original:
Research and Markets: Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

Research and Markets: Russian Federation Neurology Devices Market Outlook to 2018 – Interventional Neurology …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/6kkfzl/russian_federation) has announced the addition of GlobalData's new report "Russian Federation Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Russian Federation Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Russian Federation Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Russian Federation Neurology Devices market.

Companies Mentioned

- Medtronic, Inc.

Go here to see the original:
Research and Markets: Russian Federation Neurology Devices Market Outlook to 2018 - Interventional Neurology ...

Golden Helix Establishes Direct Presence in Japan

BOZEMAN, Mont.--(BUSINESS WIRE)--

Golden Helix has established a representative office in Japan and has selected Filgen Inc. as its exclusive distributor for the territory. Filgen will work directly with Golden Helix Japan to market and support its flagship product, SNP & Variation Suite (SVS). The software offers several packages to facilitate SNP, copy number, and next-generation sequencing data analyses.

We are excited to enter the Japanese life sciences market, as our products align with the high-quality genetic analysis work being done in Japan, said Andy Ferrin, Senior Vice-President of Business Development at Golden Helix. Having a local office supported by an experienced distributor like Filgen will enable us to better serve our customer base.

Japan has been a key area of opportunity for Golden Helix, constituting one of the countries most focused on advancing genomic studies. Having a local office will help Golden Helix take up a strong position in this important market by showing its commitment to this extremely demanding customer base, said David Leangen, the newly appointed Country Manager for Golden Helix Japan.

Says Manabu Harada, Vice-President of Filgen: Our company is one of the leading providers of life science products and services in Japan. Our customers expect a high level of quality from our offerings, and SVS fits that bill. Filgen looks forward to working with Golden Helixs representative office and is thrilled to have found a partner in this arena with such an intuitive and powerful product.

About Golden Helix

Golden Helix is a leading bioinformatics organization, specializing in sequence and array-based SNP and copy number analysis, genetic association software, and analytic services. Our innovative technologies empower scientists to determine the genetic causes of disease, transform drug discovery, develop genetic diagnostics, and advance the quest for personalized medicine. Used by hundreds of researchers at the world's top pharmaceutical, biotech, and academic research organizations, Golden Helix products and services have been cited in over 600 peer-reviewed publications. Learn more at http://www.goldenhelix.com.

About Filgen Inc.

Filgen Inc. engages in the development, manufacturing, and sales of science research equipment and provides biotechnology analysis services to the life sciences market. The company offers nano-science products, such as ultraviolet radiation ozone cleaner, spectrum osmium, dipping device, plasma film manufacture device, simple dipping device, and electron microscope trust photographing service. Filgen Inc. was founded in 2004 and is based in Nagoya, Japan. Learn more at http://www.filgen.jp.

Originally posted here:
Golden Helix Establishes Direct Presence in Japan

Groundbreaking AIDS Researcher Dies at 62

Harvard Medical School professor Norman L. Letvin 71, who was renowned as one of the scientific communitys leaders in the quest to develop an AIDS vaccine, was remembered after his death last month for not only his groundbreaking research but also his welcoming demeanor, musical gifts, and devotion to family.

Letvin, a pioneer in the use of non-human primates in AIDS vaccine research, died of pancreatic cancer on May 28 at Brigham and Women's Hospital. He was 62.

After graduating summa cum laude from Harvard, Letvin earned his M.D. from Harvard Medical School in 1975. Whilecompleting post-graduate training at the University of Pennsylvania, Letvin married Marion Stein 71, a fellow doctor. The two returned to Boston, where Letvin completed his senior residency at Massachusetts General Hospital.

In the early 1980s, Letvin discovered simian immunodeficiency virus, a virus similar to HIV that causes an AIDS-like illness in monkeys. That momentous finding led to a workable way for scientists to test HIV vaccines.

From 1994 until his death, he served as chief of the Division of Viral Pathogenesis at Beth Israel Deaconess Medical Center. He also edited the AIDS section of Science for 13 years.

Those who knew Letvin remembered his stunning intuition as a scientist.

I think he just had a natural talent for asking the right questions in science, his wife Marion said. He knew how to set up experiments in a way that whatever the results were, the data would be useful.

Though his laboratory at Beth Israel Deaconess was at the forefront of vital AIDS research, Letvin did not foster a tense working environment, colleagues recalled.

His door was always open. He made everyone feel that he was extremely approachable, said Wendy W. Yeh, a Medical School professor who worked in Letvins lab.

View post:
Groundbreaking AIDS Researcher Dies at 62

UMass Medical School Enrolling Patients in Study of Tissue Expansion for Breast Reconstruction

WORCESTER, MA--(Marketwire -06/13/12)- The University of Massachusetts Medical School (UMMS) and UMass Memorial Medical Center have enrolled their first participant in a clinical study designed to evaluate a new tissue expansion method for breast reconstruction after a mastectomy. The randomized, controlled clinical study is designed to directly compare the outcomes of the traditional saline tissue expansion method to an investigational, remote-controlled, needle-free, tissue expansion system known as The AeroForm Patient Controlled Tissue Expander System.

Tissue expansion is a process required to stretch the skin and tissue at the site of a mastectomy so that a standard saline or silicone breast implant can be placed.

"Traditionally, women undergoing breast reconstruction have had to endure a long process of inconvenient and often painful inflations using conventional saline expanders to create a pocket for a standard implant following a mastectomy," said John Castle, MD, clinical assistant professor of surgery at UMMS and plastic surgery director at the UMass Memorial Comprehensive Breast Center. "This investigational system eliminates the need for saline injections by allowing the patient to trigger the release of small amounts of compressed carbon-dioxide through the valve of a tiny chamber located inside the expander. The patient uses the remote control to gradually inflate the investigational expander in small, pre-set amounts on a daily basis at home, eliminating the need for weekly doctor visits."

Participants in this clinical trial will undergo outpatient surgery to have the investigational tissue expansion device implanted. They will then use a wireless dose controller to trigger the release of small, regulated amounts of carbon-dioxide to fill the tissue expander, according to a protocol directed by their surgeon. Once the tissue is adequately expanded, participants will return to UMass Memorial Medical Center to have the implant surgically inserted. During earlier feasibility trials, the average expansion time associated with the remote-controlled tissue expander was 15 days, a fraction of the time required using traditional expanders which can take months to achieve full expansion.

Patients in the study will be randomly selected to receive the investigational expander or a traditional saline expander. The patients who receive the investigational expander will use a wireless remote control to trigger the release of small, regulated amounts of carbon-dioxide to fill the tissue expander, according to a protocol directed by Dr. Castle. Once the tissue is adequately expanded, the patient will return to have the expander removed and a standard implant placed.

The current standard of care in tissue expansion involves implanting a saline expander under the skin and pectoral muscle following a mastectomy procedure. The patient returns to her doctor weekly for bolus saline injections, which many patients say is the most painful, difficult part of the reconstruction process. The traditional saline process can take as long as five to six months.

UMass Memorial Medical Center and other hospitals across the U.S. are participating in the study. Enrollment will continue until a total of 92 AeroForm expanders and 46 saline expanders have been implanted in patients. AeroForm will be evaluated based on its ability to successfully and safely expand the tissue to the point that the expander can be replaced with a standard breast implant. Secondary measurements will include the average number of days needed to achieve the desired expansion, total reconstruction time, pain and patient satisfaction.

The AeroForm Patient Controlled Tissue Expander was designed and manufactured by AirXpanders, a medical device company in Palo Alto, CA. The U.S. Food and Drug Administration (FDA) has granted AirXpanders an Investigational Device Exemption (IDE) to conduct the study and it has been approved for enrollment by the U Mass Memorial Medical Center Review Board.

For more information on the study, please visit clinicaltrials.gov. (NCT01425268) If you or someone you know is interested in joining the study, please call 508-334-7692.

About the University of Massachusetts Medical SchoolThe University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attracts more than $270 million in research funding annually, 80 percent of which comes from federal funding sources. The mission of the Medical School is to advance the health and well-being of the people of the commonwealth and the world through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. For more information, visit http://www.umassmed.edu.

See more here:
UMass Medical School Enrolling Patients in Study of Tissue Expansion for Breast Reconstruction

Bloomberg fires back at "nanny" critics: It's part of government's role

(CBS News) New York City Mayor Michael Bloomberg shrugged off criticism of his controversial public health initiatives, saying that "if government's purpose isn't to improve the health and longevity of its citizens, I don't know what its purpose is."

Bloomberg most recently put forth a plan to ban the sale of sugary drinks larger than 16 ounces from the city's eateries, street carts and stadiums.

The proposal has been sharply criticized, in some cases by beverage and fast food companies as a case of government overreach.

He's also been criticized for previous efforts to, among other things, ban smoking in public places and the use of trans-fats in restaurant foods. Some have gone so far as to mock has as being like a "nanny."

But on "CBS This Morning," Bloomberg fired back, saying, "We're not here to tell anybody what to do. But we certainly have an obligation to tell them what's the best science and best medicine says is in their interest.

Bloomberg group dangles $9M for ways to aid city life

"If you want to smoke, I think it's pretty ridiculous, you shouldn't. But I don't think we should take away your right to smoke."

Bloomberg pointed out that life expectancy iin New York City exceeds the national average by three years, noting that all the progress has come since he took office a decade ago.

He brushed aside all the attention the proposed ban has gotten, saying, "That's just because it's the story of the week. That'll get blended into lots of other things."

Bloomberg applauded the efforts of some companies that "really understand," such as Coca-Cola, Pepsi and Disney.

Go here to see the original:
Bloomberg fires back at "nanny" critics: It's part of government's role

Those Long Telomeres Inherited from an Older Father Give You Longevity

E-mail this page to a friend!

Senior Citizen Longevity & Statistics

Those Long Telomeres Inherited from an Older Father Give You Longevity

Short telomeres a cause of ill health that occurs with aging long telomeres promote slower aging

Fluorescence-stained chromosomes (red) on a microscope slide. Telomere sequences (yellow) reside at the ends of each chromosome. More about telomeres from University of Utah below main story.

June 13, 2012 - Senior citizens most of them, anyway - are fond of trying to find reasons they are going to live longer. Well, here is a new one for you to contemplate. Researchers say that if your father conceived you late in life, you probably inherited some life-extending benefits long telomeres.

Its all based on a biological assumption that a slow pace of aging requires the body to invest more resources in repairing aging cells and tissues.

Researchers from Northwestern University say that our bodies might increase these investments to slow the pace of aging if our father and grandfather waited until they were older before having children.

Related Stories

Here is the original post:
Those Long Telomeres Inherited from an Older Father Give You Longevity

Smoking, drinking, being overweight have little effect on sperm count: study

Drinking, smoking or being fat make little difference to how well a mans sperm cells can swim, a new study has found.

The peer-reviewed findings to be published on Wednesday in the medical journal Human Reproduction fly in the face of the common advice that men having fertility problems should stick to a healthier lifestyle.

The study looked at sperm samples from 2,249 British men recruited from fertility clinics and andrology labs.

The researchers found that men who wore briefs rather than boxer shorts, had testes surgery, or did manual work that would expose them to chemicals, were more likely to have a low motile sperm count.

However, no relation was found to consumption of alcohol, use of tobacco or recreational drugs or high body mass index, the article says.

In fact, having very low body mass index appeared to have a negative impact on sperm quality, although that sample size was too minute to be meaningful, the study said.

One of the researchers said the results suggest that men shouldnt wait until they have developed a healthier lifestyle before they try to procreate, especially if age is a crucial factor for their spouses.

Success in fertility treatment is an issue for the couple and not simply the male partner the prime issue in delaying treatment is that success drops dramatically with the age of the female partner, said Nicola Cherry, an epidemiologist at the University of Albertas faculty of medicine.

Guidelines from the Public Health Agency of Canada and the Guide to Infertility booklet produced by Assisted Human Reproduction Canada both say that smoking and alcohol consumption decrease success rates.

Perhaps where fertility treatment is prohibitively expensive it seems better to suggest a healthy lifestyle rather than just to advise, keep trying, Dr. Cherry said.

More here:
Smoking, drinking, being overweight have little effect on sperm count: study

Heavy Drinking, Smoking Won't Harm Men's Sperm

variety of beers

TUESDAY, June 12 (HealthDay News) -- When a man drinks to excess, smokes or otherwise behaves unhealthily, it probably won't damage his sperm, a new British study contends.

But, fertility experts who reviewed the new report, published June 12 in Human Reproduction, weren't in full agreement with the findings.

"I am concerned that this limited and isolated study will convey the wrong message to couples desiring to become parents," said Dr. Natan Bar-Chama, director of the Center of Male Reproductive Health at Mt. Sinai Hospital in New York City.

The study included more than 2,200 men from 14 fertility clinics around the United Kingdom who completed detailed questionnaires about their lifestyle habits. The researchers compared this information to the levels of swimming sperm ejaculated by the men.

[Read: Fatty Foods May Harm Men's Sperm.]

Some factors did impact sperm health. For example, men who had low levels of swimming sperm were 2.5 times more likely to have had prior testicular surgery, twice as likely to be black, and 30 percent more likely to have manual labor jobs, not wear boxer shorts (vs. briefs or no underwear), or not to have previously conceived a child.

On the other hand, the researchers also found that men's weight and their use of tobacco, alcohol and recreational drugs had little effect on levels of swimming sperm.

"Despite lifestyle choices being important for other aspects of our health, our results suggest that many lifestyle choices probably have little influence on how many swimming sperm [men] ejaculate," Dr. Andrew Povey, from the University of Manchester's School of Community Based Medicine, said in a university news release.

The findings suggest that lifestyle advice given to infertile men needs to be changed, the researchers added.

More here:
Heavy Drinking, Smoking Won't Harm Men's Sperm

Synthesis of genetically evolved semiconductor material

SANTA BARBARA In the not-too-distant future, scientists may be able to use DNA to grow their own specialized materials, thanks to the concept of directed evolution. UC Santa Barbara scientists have, for the first time, used genetic engineering and molecular evolution to develop the enzymatic synthesis of a semiconductor.

"In the realm of human technologies it would be a new method, but it's an ancient approach in nature," said Lukmaan Bawazer, first author of the paper, "Evolutionary selection of enzymatically synthesized semiconductors from biomimetic mineralization vesicles," published in the Proceedings of the National Academy of Sciences. Bawazer, who was a Ph.D. student at the time, wrote the paper with co-authors at UC Santa Barbara's Interdepartmental Graduate Program in Biomolecular Science and Engineering; Institute for Collaborative Biotechnologies; California NanoSystems Institute and Materials Research Laboratory; and Department of Molecular, Cellular and Developmental Biology. Daniel Morse, UC Santa Barbara professor emeritus of biochemistry of molecular genetics, directed the research.

Using silicateins, proteins responsible for the formation of silica skeletons in marine sponges, the researchers were able to generate new mineral architectures by directing the evolution of these enzymes. Silicateins, which are genetically encoded, serve as templates for the silica skeletons and control their mineralization, thus participating in similar types of processes by which animal and human bones are formed. Silica, also known as silicon, is the primary material in most commercially manufactured semiconductors.

In this study, polystyrene microbeads coated with specific silicateins were put through a mineralization reaction by incubating the beads in a water-in-oil emulsion that contained chemical precursors for mineralization: metals of either silicon or titanium dissolved in the oil or water phase of the emulsion. As the silicateins reacted with the dissolved metals, they precipitated them, integrating the metals into the resulting structure and forming nanoparticles of silicon dioxide or titanium dioxide.

With the creation of a silicatein gene pool, through what Bawazer only somewhat euphemistically calls "molecular sex" the combination and recombination of various silicatein genetic materials the scientists were able to create a multitude of silicateins, and then select for the ones with desired properties.

"This genetic population was exposed to two environmental pressures that shaped the selected minerals: The silicateins needed to make (that is, mineralize) materials directly on the surface of the beads, and then the mineral structures needed to be amenable to physical disruption to expose the encoding genes," said Bawazer. The beads that exhibited mineralization were sorted from the ones that didn't, and then fractured to release the genetic information they contained, which could either be studied or evolved further.

The process yielded forms of silicatein not available in nature, that behaved differently in the formation of mineral structures. For example, some silicateins self-assembled into sheets and made dispersed mineral nanoparticles, as opposed to more typical agglomerated particles formed by natural silicateins. In some cases, crystalline materials were also formed, demonstrating a crystal-forming ability that was acquired through directed evolution, said Bawazer.

Because silicateins are enzymes, said Bawazer, with relatively long amino acid chains that can fold into precise shapes, there is the potential for more functionality than would be possible using shorter biopolymers or more traditional synthetic approaches. In addition, the process could potentially work with a variety of metals, to evolve different types of materials. By changing the laboratory-controlled environments in which directed evolution occurs, it will be possible to evolve materials with specific capacities, like high performance in an evolved solar cell, for example.

"Here we've demonstrated the evolution of material structure; I'd like to take it a step further and evolve material performance in a functional device," said Bawazer.

Research for this paper was supported by the U.S. Department of Energy.

Continue reading here:
Synthesis of genetically evolved semiconductor material

Scientists synthesize first genetically evolved semiconductor material

ScienceDaily (June 13, 2012) In the not-too-distant future, scientists may be able to use DNA to grow their own specialized materials, thanks to the concept of directed evolution. UC Santa Barbara scientists have, for the first time, used genetic engineering and molecular evolution to develop the enzymatic synthesis of a semiconductor.

"In the realm of human technologies it would be a new method, but it's an ancient approach in nature," said Lukmaan Bawazer, first author of the paper, "Evolutionary selection of enzymatically synthesized semiconductors from biomimetic mineralization vesicles," published in the Proceedings of the National Academy of Sciences. Bawazer, who was a Ph.D. student at the time, wrote the paper with co-authors at UCSB's Interdepartmental Graduate Program in Biomolecular Science and Engineering; Institute for Collaborative Biotechnologies; California NanoSystems Institute and Materials Research Laboratory; and Department of Molecular, Cellular and Developmental Biology. Daniel Morse, UCSB professor emeritus of biochemistry of molecular genetics, directed the research.

Using silicateins, proteins responsible for the formation of silica skeletons in marine sponges, the researchers were able to generate new mineral architectures by directing the evolution of these enzymes. Silicateins, which are genetically encoded, serve as templates for the silica skeletons and control their mineralization, thus participating in similar types of processes by which animal and human bones are formed. Silica, also known as silicon, is the primary material in most commercially manufactured semiconductors.

In this study, polystyrene microbeads coated with specific silicateins were put through a mineralization reaction by incubating the beads in a water-in-oil emulsion that contained chemical precursors for mineralization: metals of either silicon or titanium dissolved in the oil or water phase of the emulsion. As the silicateins reacted with the dissolved metals, they precipitated them, integrating the metals into the resulting structure and forming nanoparticles of silicon dioxide or titanium dioxide.

With the creation of a silicatein gene pool, through what Bawazer only somewhat euphemistically calls "molecular sex" -- the combination and recombination of various silicatein genetic materials -- the scientists were able to create a multitude of silicateins, and then select for the ones with desired properties.

"This genetic population was exposed to two environmental pressures that shaped the selected minerals: The silicateins needed to make (that is, mineralize) materials directly on the surface of the beads, and then the mineral structures needed to be amenable to physical disruption to expose the encoding genes," said Bawazer. The beads that exhibited mineralization were sorted from the ones that didn't, and then fractured to release the genetic information they contained, which could either be studied, or evolved further.

The process yielded forms of silicatein not available in nature, that behaved differently in the formation of mineral structures. For example, some silicateins self-assembled into sheets and made dispersed mineral nanoparticles, as opposed to more typical agglomerated particles formed by natural silicateins. In some cases, crystalline materials were also formed, demonstrating a crystal-forming ability that was acquired through directed evolution, said Bawazer.

Because silicateins are enzymes, said Bawazer, with relatively long amino acid chains that can fold into precise shapes, there is the potential for more functionality than would be possible using shorter biopolymers or more traditional synthetic approaches. In addition, the process could potentially work with a variety of metals, to evolve different types of materials. By changing the laboratory-controlled environments in which directed evolution occurs, it will be possible to evolve materials with specific capacities, like high performance in an evolved solar cell, for example.

"Here we've demonstrated the evolution of material structure; I'd like to take it a step further and evolve material performance in a functional device," said Bawazer.

Research for this paper was supported by the U.S. Department of Energy.

Link:
Scientists synthesize first genetically evolved semiconductor material

'Gay gene' survives through generations as female relatives of homosexual men 'have more babies'

By Eddie Wrenn

PUBLISHED: 10:29 EST, 13 June 2012 | UPDATED: 10:29 EST, 13 June 2012

Research in Italy suggests that a 'gay gene' survive through the generations via family members

Researchers believe that male homosexuality may be due to a gene carried by mothers.

Evolution suggests that homosexuality as a trait would not last long, as it discourages sex, with women and therefore procreation.

But a study by Andrea Camperio Ciani, from the University of Padova in Italy, spots a correlation between gay men and their mothers and maternal aunts, who tend to have significantly more children than the relatives of straight men.

They theorise that this leads credence to the 'balancing selection hypothesis', which suggest that a gene which leads to homosexuality also leads to high reproduction among their female relatives.

As such, while the 'gay gene' may not get passed down directly, it will survive through the generations via the family.

The gene or genes which causes this behaviour is not yet known, but the report by Ciani suggests that it resides on the X chromosone, of which men inherit one.

Originally, the team considered the hypothesis that the gene would affect men and women in different ways - making the man homosexual, and making females more promiscuous.

Read more:
'Gay gene' survives through generations as female relatives of homosexual men 'have more babies'

FIFA 12: Exploring The Individual Player Chemistry Myth – Video

13-06-2012 10:29 Wanted to test it out and prove that individual player chemistry does not make a difference on the performance. If you want me to continue this, let me know. ----------------------------------------------------------------------------- Follow Me: Subscribe To My 2nd Channel: Become A Fan: Follow My channel: Get A TROUTED T-shirt At: Make A Fantasy Premier League Team Here http & Then Join My League With This Code: 1241775-282939 Get your Kontrol Freek's here (for 10% off, promo code: TROUT):

Read the rest here:
FIFA 12: Exploring The Individual Player Chemistry Myth - Video

Peter Carey's The Chemistry of Tears

Author Peter Carey starts every novel with the big argument what is wrong with the American approach to democracy in Parrot and Olivier in America; how do Australians live with the convict stain in The True History of the Kelly Gang.

In his most recent novel, The Chemistry of Tears, he's concerned with nothing less than the fate of the earth. The story of a contemporary museum curator who is restoring an automaton a clockwork silver swan takes place in 2010, the year the BP oil spill threatened environmental disaster in the Gulf of Mexico. A parallel story takes place in the 19th century as Henry Brandling struggles to get the swan made as a gift for his consumptive son.

If you ask why are you interested in the 19th century, I would say, because were living in it, Carey said in an interview with CBC News. Were living with the consequences of it. We argue with the 19th century capitalists, growth is good we still talk like that

At the same time we know that growth is killing us. At the same time, we know were living on the resources of a planet and a half. The system will break with all the destruction man can do. So in both those cases were living in the 19th century were living in 19th century with its mad, technological optimism. We have the idea that we get richer by making stuff and then throwing it away.

The prophet that Carey gets to carry his message in The Chemistry of Tears is Amanda Snyde a crazy young woman who is off her medication and who may also be a spy for the powerful manager of the fictional Swinburne Museum in London, where much of the story is set. Amanda is obsessed with the Gulf oil spill, transfixed by the webcam that shows the stain spreading across the ocean. She sees it as an end-of-days event, but then, she also believes that the internal combustion engine is the work of aliens, who bequeathed it to humankind to lead us toward self-destruction.

Shes nuts, but shes correct, Carey says, waggishly, adding that he had to make her unhinged because I wanted someone who could give a poetic expression of a bigger truth.

Carey is Australian born the youngest son of a man who ran a car dealership and admired Henry Fords invention. Carey himself has made his home in New York for the past 22 years, teaching creative writing. now at Hunter College. Hes won the Booker Prize twice, for Oscar and Lucinda and The True History of the Kelly Gang. The Chemistry of Tears is his 18th book.

The main contemporary character, the curator Catherine Gehrig, is the first Carey conceived and the woman who provided a narrative arc to the story he tells. Shes been in a secret affair with a married man and he dies, leaving her so paralyzed by grief she does not trust her own judgment. She cannot grieve openly, and her behaviour is so erratic she is moved to an annex of the Swinburne Museum and given a project meant to keep her out of harms way to reconstruct an automaton that arrives packed in pieces in numerous tea chests.

Im really very fond of her, Im fond of all my characters. I find her behaviour totally reasonable, Carey says of Catherine, who is more concerned about breaking into her lovers account and deleting all the e-mails theyve exchanged than with her odd assistant, Amanda, or with her job. Ive never experienced what Cat did, but I have loved someone. Its not hard to imagine.

The 19th century character Henry Brandling who seeks out a clockmaker in Karlsruhe, Germany to make an automaton is equally perturbed by grief, both for his failed marriage and over the illness of his child, Percy. Brandling has found a drawing of Vaucansons duck, an automaton that eats and excretes, by the real French inventor Jacques de Vaucanson. He wants a similar device for his consumptive son, thinking that it will make the boy laugh and encourage him to live.

Read this article:
Peter Carey's The Chemistry of Tears

UCB and ChemDiv Research Institute Conclude First Phase of Discovery Chemistry Collaboration

SAN DIEGO, CA and BRUSSELS, BELGIUM and MOSCOW--(Marketwire -06/13/12)- UCB and ChemDiv have successfully concluded the first phase of their 2011 collaborative discovery chemistry program executed with ChemDiv's Moscow subsidiary, the ChemDiv Research Institute.

In the course of the collaboration, ChemDiv prepared hundreds of complex and highly targeted medicinal chemical scaffolds, building blocks and templates as part of a complete discovery chemistry solution. The partners' joint steering committee review of progress milestones confirmed the success of the ongoing collaboration, which carries an initial term of 2 years, and can further be extended.

UCB's Benoit Kenda remarked, "UCB had been looking for a partner that has a very strong standing in scaffolds ideation, library preparation and could contribute to UCB's already large and diverse compounds library, in particular in developing special libraries, according to UCB's specifications, and need to inhibit novel Biotargets. We are very happy to have found a partner with ChemDiv which is equally strong in developing novel scaffolds and templates.

Dmitry Kravchenko, CEO of ChemDiv Research Institute, said: "We are pleased that our collaboration with UCB proceeds with continuing success, as acknowledged by both parties. Our success in developing this comprehensive chemistry solution for UCB was enabled by ChemDiv's proprietary Chemistry On Demand design and development system, which encompasses over 2B of druggable, target-relevant and validated structure/synthetic space. We are committed to further extending our collaboration with UCB as a long term relationship."

About ChemDiv Research Institute:

ChemDiv and the ChemDiv Research Institute (CDRI) comprise a fully integrated discovery and development CRO based in San Diego and at the ChemRar High Tech Center in Moscow. CDRI collaborates with pharmaceutical and biotech partners by enabling them to accelerate R&D programs to higher value clinical inflection points. ChemDiv and its CDRI subsidiary offer integrated Discovery outSource solutions covering the complete range of disciplines, in multiple therapeutic areas (CNS, oncology, inflammation, metabolic, infectious diseases, and others), from discovery research and preclinical development, through accelerated Proof of Concept, and to market registration.

Follow this link:
UCB and ChemDiv Research Institute Conclude First Phase of Discovery Chemistry Collaboration

Royal Society of Chemistry Selects Neolane for Marketing Automation

TWICKENHAM, England--(BUSINESS WIRE)--

Conversational marketing technology provider Neolane today announced the Royal Society of Chemistry (RSC) in the United Kingdom as a new customer. The organisation will implement the Neolane Leads marketing automation software platform to improve the effectiveness of its publishing and membership marketing activities and to alert members, readers and authors to new content, activities and events specifically relevant to them.

We considered marketing automation to help us form better and higher value relationships with members, authors and readers through understanding and serving their specialised interests more closely, said Richard Crouch, marketing director at the Royal Society of Chemistry. Neolane Leads will help us define complex communication workflows and then engage in automated one-to-one conversations cost-effectively, cross-channels including via social media.

He continued: Sophisticated analysis and reporting capabilities within Neolane will help us to optimise marketing effort and the value of the communications we send to each customer, whilst excellent data protection capabilities will ensure customers details are kept secure.

RSC operates in a business to business to consumer (B2B2C) environment where customers are both companies and institutions and the scientists, information professionals and students that work or study there. Neolane Leads will collect campaign responses and inbound data from web forms and events, automatically fulfil requests for marketing collateral and content and update profiles in the single customer view. Later on, RSC will also use the platform to score and track leads from inception through to maturity, integrating it with the societys sales force automation system. As leads become hot prospects, they will then be passed directly to relevant sales teams for conversion.

Neolane Leads addresses the full breadth of marketing needs spanning demand generation, customer communications, and lead management, said Martin Smith, head of marketing Neolane (UK). In a single application, RSC will be able to feed, visualise, and monitor its marketing pipeline, plan and execute demand generation, implement customer communications programmes, and nurture leads all while demonstrating revenue accountability.

About Neolane

Neolane provides the only conversational marketing technology that empowers organizations to build and sustain one-to-one lifetime dialogues, dramatically increasing revenue and marketing efficiency. Born digital, withbest-in-class email and inbound-outbound channel fusion capabilities architected into a single code-based platform, marketers achieve results in record time. Neolane is easy to use for both power and casual users, but powerful enough to drive the most sophisticated marketing strategies. Future proof, Neolane has a track record of enabling its customers to adapt to new customer engagement challenges and exploit opportunities more quickly than their competition.Neolane is used by more than 350 of the worlds leading companies including Alcatel Lucent, barnesandnoble.com, Orange, Sears Canada, Sephora Europe and Sony Music. Visit http://www.neolane.com and read our blog The Cross-Channel Conversation.

About the Royal Society of Chemistry

The Royal Society of Chemistry is the UK Professional Body for chemical scientists and an international Learned Society for the chemical sciences with more than 48,000 members worldwide. It is a major international publisher of chemical information, supports the teaching of chemical sciences at all levels and is a leader in bringing science to the public. http://www.rsc.org

See the original post:
Royal Society of Chemistry Selects Neolane for Marketing Automation